Could This Twice-A-Year HIV Shot Be the Plot Twist Science Didn’t See Coming?
Added on June 19, 2025 inEntertainment News Cards, RECENT NEWS CARDS
Popular
Numerology Meets Netflix: Get Your Daily Dose of Cosmic Cinema Suggestions Powered By Our AI Astrologer. Find The Show Or Movie You Were Meant To See!
Then Join Our FREE Newsletter To Watch Your Choice Of Movies And Shows For FREE Plus Get The Latest Entertainment News And Updates!
Ever wonder if the stars could align not just for your love life or career but for a groundbreaking medical breakthrough? Well, as Mercury dances retrograde and challenges our usual pace, the U.S. has just greenlit something revolutionary — a twice-a-year shot to prevent HIV. This isn’t your everyday jab; it’s a potential game-changer crafted by Gilead Sciences, cleverly named lenacapavir. Imagine nearly wiping out new infections among high-risk folks, outperforming those forgetful daily pills that so many have struggled to keep up with. While the cosmic quest for an actual HIV vaccine continues, this new shot might just be the cosmic nudge we’ve all been waiting for to protect millions globally. Curious how this aligns with the tides of global health and access? Let’s dive in. LEARN MORE
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.
Auto Amazon Links: No products found.
){kind=link}